Stock Events

Stock Events

Lysogene 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap37.49B
Biogen focuses on neurodegenerative diseases, directly competing with Lysogene's CNS and lysosomal storage disorders treatments.
Pfizer
PFE
Mkt Cap173.95B
Pfizer has investments in gene therapy for rare diseases, competing in the same therapeutic areas as Lysogene.
Sarepta Therapeutics
SRPT
Mkt Cap1.97B
Sarepta Therapeutics focuses on the discovery and development of RNA-based therapeutics and gene therapy for rare diseases, similar to Lysogene's focus areas.
Abeona Therapeutics
ABEO
Mkt Cap248.75M
Abeona Therapeutics specializes in gene and cell therapies for serious genetic diseases, directly competing with Lysogene's gene therapy approach.
PTC Therapeutics
PTCT
Mkt Cap5.01B
PTC Therapeutics focuses on the discovery and commercialization of novel medicines, including treatments for CNS disorders, competing with Lysogene.
Vertex Pharmaceuticals
VRTX
Mkt Cap141.65B
Vertex Pharmaceuticals engages in developing and commercializing therapies for treating cystic fibrosis and other serious diseases, indirectly competing with Lysogene by targeting overlapping patient populations.

About

Lysogene S.A. engages in the research and clinical development of gene therapy for neurodegenerative disorders. Its clinical programs include LYS-SAF302, which is in Phase II/III clinical trial for the treatment of mucopolysaccharidosis type IIIA; and LYS-GM101 that is in Phase I/II trial for the treatment of GM1 gangliosidosis. The company has a collaborative research collaboration with the Weizmann Institute of Science for developing a novel AAV gene therapy approach for neuronopathic gaucher disease, parkinson disease, and other diseases. Lysogene S.A. was founded in 2009 and is based in Neuilly-sur-Seine, France.
Show More
CEO
Ms. Karen Pignet-Aiach
Employees
22
Country
France
ISIN
FR0013233475
WKN
000A2DLMU

Listings

MU
DE
4W4.MU

0 Comments

Share your thoughts

FAQs

What is Lysogene stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Lysogene stocks are traded under the ticker 4W4.MU.
How many employees does Lysogene have?▼
As of November 2, 2026, the company has 22 employees.
In which sector is Lysogene located?▼
Lysogene operates in the Other sector.
When did Lysogene complete a stock split?▼
Lysogene has not had any recent stock splits.
Where is Lysogene headquartered?▼
Lysogene is headquartered in Neuilly-sur-Seine, France.